Healthcare -
Biotechnology - NASDAQ - US
$ 39.24
4.39 %
$ 2.41 B
Market Cap
9.28
P/E
PTGX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities PTGX - Protagonist Therapeutics, Inc.
170 M
LAST VALUE
14.55%
2 YEAR CAGR
47.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR